Financings in Brief: Spectral Diagnostics
This article was originally published in The Gray Sheet
Spectral Diagnostics: Cardiac diagnostics company completes the sale of 750,000 special warrants for $8.90 (Canadian) each. The warrants each entitle holders to "acquire one common share of Spectral for no additional consideration," the company says. First Marathon Securities served as placement agent for the offering...
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.